药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Cysteamine
Trimazosin
Clomipramine may decrease the antihypertensive activities of Trimazosin.
Cysteamine
Indoramin
Clomipramine may decrease the antihypertensive activities of Indoramin.
Cysteamine
Temocapril
Clomipramine may decrease the antihypertensive activities of Temocapril.
Cysteamine
Ferulic acid
Clomipramine may decrease the antihypertensive activities of Ferulic acid.
Cysteamine
Diethylnorspermine
Clomipramine may decrease the antihypertensive activities of Diethylnorspermine.
Cysteamine
Dexpropranolol
Clomipramine may decrease the antihypertensive activities of Dexpropranolol.
Cysteamine
Spirapril
Clomipramine may decrease the antihypertensive activities of Spirapril.
Cysteamine
Saprisartan
Clomipramine may decrease the antihypertensive activities of Saprisartan.
Cysteamine
Cilazapril
Clomipramine may decrease the antihypertensive activities of Cilazapril.
Cysteamine
Rescinnamine
Clomipramine may decrease the antihypertensive activities of Rescinnamine.
Cysteamine
Deserpidine
Clomipramine may decrease the antihypertensive activities of Deserpidine.
Cysteamine
Omapatrilat
Clomipramine may decrease the antihypertensive activities of Omapatrilat.
Cysteamine
Teriflunomide
The serum concentration of Clomipramine can be decreased when it is combined with Teriflunomide.
Cysteamine
Flibanserin
The serum concentration of Flibanserin can be increased when it is combined with Clomipramine.
Cysteamine
Deferasirox
The serum concentration of Clomipramine can be increased when it is combined with Deferasirox.
Cysteamine
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Clomipramine.
Cysteamine
Ivabradine
Ivabradine may increase the QTc-prolonging activities of Clomipramine.
Flurandrenolide
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorprothixene is combined with Oliceridine.
Flurandrenolide
Ziconotide
The risk or severity of CNS depression can be increased when Chlorprothixene is combined with Ziconotide.
Flurandrenolide
Lasmiditan
The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Lasmiditan.